Raanana, Israel

Niv Papo

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2001-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Niv Papo: Innovator in Bone Disease Treatment

Introduction

Niv Papo is a notable inventor based in Raanana, Israel. He has made significant contributions to the field of biotechnology, particularly in the treatment of bone-associated diseases. With a total of 3 patents, his work focuses on innovative compositions and methods that aim to improve health outcomes for patients suffering from these conditions.

Latest Patents

Niv Papo's latest patents include groundbreaking work on compositions and methods for the treatment of bone-associated diseases. One of his notable inventions is a mutant M-CSF protein that comprises an αβ integrin binding motif. This pharmaceutical composition is designed to treat and prevent diseases associated with increased bone resorption. His research provides valuable insights into the potential for new therapeutic approaches in managing bone health.

Career Highlights

Throughout his career, Niv Papo has worked with esteemed institutions such as the National Institute for Biotechnology in the Negev Ltd. and the Ben-Gurion University of the Negev Research and Development Authority. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in biotechnology.

Collaborations

Niv Papo has collaborated with several professionals in his field, including Noam Levaot and Yuval Zur. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the biotechnology sector.

Conclusion

Niv Papo stands out as an influential inventor in the realm of bone disease treatment. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient care. His contributions are paving the way for future developments in the treatment of bone-associated diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…